In a groundbreaking study, researchers at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are investigating the potential benefits of exercise and intermittent fasting for patients with advanced breast cancer. Funded by a $4-million, five-year grant from the National Cancer Institute, the phase II randomized trial aims to include 260 women. The study will focus on patients starting a CDK4/6 inhibitor medication in combination with hormonal therapy.
Key Points:
- The research aims to explore if exercise and intermittent fasting can help patients better manage treatment-related side effects like fatigue.
- The study builds on a pilot project that showed promising results in reducing fatigue and improving the quality of life among 30 women with advanced breast cancer.
- Outcomes will be assessed at 12 weeks, six months, and one year after enrollment.
The study is particularly timely, given that October is Breast Cancer Awareness Month. “Our research has the potential to improve treatment tolerability, quality of life, and possibly life duration for women living with advanced breast cancer,” said Tracy Crane, PhD, RDN, one of the principal investigators.
For more details, read the full article on News-Medical.net.